1
Ravi Laxman
Ziyun Wang, Chongying Xu, Ravi K Laxman, Thomas H Baum, Bryan C Hendrix, Jeffrey F Roeder: Composition and method for low temperature deposition of silicon-containing films such as films including silicon, silicon nitride, silicon dioxide and/or silicon-oxynitride. Advanced Technology Materials, July 28, 2011: US20110183528-A1

Silicon precursors for forming silicon-containing films in the manufacture of semiconductor devices, such as low dielectric constant (k) thin films, high k gate silicates, low temperature silicon epitaxial films, and films containing silicon nitride (Si3N4), siliconoxynitride (SioxNy) and/or silicon ...


2
Tarran Jones
David M Hilbert, Tarran Jones, David G Williams: Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease. Medimmune, July 28, 2011: US20110182887-A1

The present invention provides chimeric and humanized versions of anti-CD22 mouse monoclonal antibody, HB22.7. The anti-CD22 antibodies of the invention comprise four human or humanized framework regions of the immunoglobulin heavy chain variable region (“VH”) and four human or humanized framework r ...


3
MAISANO FRANCESCO: Tricuspid valve repair using tension. 4TECH, Sanford T Colb & Co, July 28, 2011: WO/2011/089601 (57 worldwide citation)

A method is provided, including implanting at least a first tissue-engaging element (60a) in a first portion of tissue in a vicinity of a heart valve (4) of a patient, implanting at least a second tissue-engaging element (60b) in a portion of a blood vessel (8, 10) that is in contact with an atrium ...


4
SINGH JUSWINDER: Heteroaryl compounds and uses thereof. AVILA THERAPEUTICS, Huck Emilie Porter, July 28, 2011: WO/2011/090760 (55 worldwide citation)

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.


5
DOMINGUEZ CELIA: Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof. CHDI, Stevens Lauren L, July 28, 2011: WO/2011/091153 (47 worldwide citation)

Certain chemical entities are provided herein. Also provided are pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO act ...


6
Takashino Tomoyuki: 治療用処置具、治療用処置装置および治療処置方法 (JA), Treatment tool, treatment device, and treatment method (EN). OLYMPUS MEDICAL SYSTEMS, Suzuye Takehiko, July 28, 2011: WO/2011/089717 (43 worldwide citation)

Disclosed is a treatment tool (12) for joining living tissues, which comprises: at least a pair of holding members (52, 54) for holding living tissues; energy output parts (92, 94) which are provided on at least one of the holding members and connected to an energy source (14) for the purpose of sup ...


7
BASKARAN SUBRAMANIAN: Chemical compounds. GLAXOSMITHKLINE, Brink Robert H, July 28, 2011: WO/2011/091446 (27 worldwide citation)

Disclosed are compounds of Formula II. Also disclosed are salts of the compounds, pharmaceutical compositions comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.


8
Töllner Thomas: Fluid pump having a radially compressible rotor. ECP ENTWICKLUNGSGESELLSCHAFT MBH, Pfenning Meinig & Partner Gbr, July 28, 2011: WO/2011/089022 (27 worldwide citation)

To design the rotor (6, 6', 6", 6''', 60, 60' ) as compressible in the radial direction in a fluid pump, in particular for microinvasive medical use, said rotor is configured as stretchable in its longitudinal direction (16) by push elements and pull elements acting axially on it.


9
HOOK DAVID: Intermediates of neutral endopeptidase inhibitors and preparation method thereof. Novartis, Zhongzi Law Office, July 28, 2011: WO/2011/088797 (27 worldwide citation)

Disclosed are intermediates for the manufacture of neutral endopeptidase (NEP) inhibitors or prodrugs thereof, and preparation method thereof. In particular, the said NEP inhibitors comprise a γ-amino-δ-biphenyl-α-methylalkanoic acid, or acid ester, backbone, such as N-(3-carboxyl-1-oxopropyl)-(4S)- ...


10
Voss Axel: Medical device and method for operating a medical device. SWITECH MEDICAL, Molnia David, July 28, 2011: WO/2011/089270 (24 worldwide citation)

The application pertains to a medical device (1) including a treatment unit (4) for treating patients, an activation device (3) for activating the treatment unit, and an input device (2) for entering an activation code, the input device being coupled to the activation device (3), and the activation ...